Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil effects on exertional dyspnea in mild to moderate COPD
RBR-4qhkf4Recruiting
- Sponsor
- Universidade Federal do Rio Grande do Sul
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in chronic obstructive pulmonary disease (COPD) comparing COPD crossover: sildenafil and placebo with Control group: placebo only (2 arms). Primary endpoints: Dyspnea during exercise and Inspiratory capacity during exercise. Started Jan 2019; status: recruiting.
02
Drugs
sildenafil
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on RBR-4qhkf4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4qhkf4.